Acute drug treatment of migraine attack

Neurological Sciences

Volumn 25, Issue SUPPL. 3, 2004, Pages

  Narbone, M C ^a,b   Abbate, M ^b   Gangemi, S ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Acute migraine treatment; Advance; Effective drugs

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; ANTIEMETIC AGENT; ANTIMIGRAINE AGENT; CAFFEINE; DICLOFENAC; DIHYDROERGOTAMINE; DOMPERIDONE; ELETRIPTAN; ERGOT ALKALOID; ERGOTAMINE; ERGOTAMINE TARTRATE; IBUPROFEN; KETOPROFEN; LYSINE ACETYLSALICYLATE; METOCLOPRAMIDE; NAPROXEN; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PLACEBO; PROCHLORPERAZINE; RIZATRIPTAN; SUMATRIPTAN; TOLFENAMIC ACID; ZOLMITRIPTAN; SEROTONIN AGONIST;

ABDOMINAL PAIN; ACUTE DRUG ADMINISTRATION; ANGINA PECTORIS; ASTHENIA; BRADYCARDIA; BRAIN DISEASE; CLINICAL TRIAL; DIARRHEA; DIZZINESS; DROWSINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INHIBITION; EPIGASTRIC PAIN; HEADACHE; HEAT SENSATION; HUMAN; HYPERTENSION; INJECTION SITE REACTION; INTERMITTENT CLAUDICATION; KIDNEY DISEASE; LEG CRAMP; MIGRAINE; NAUSEA AND VOMITING; PALLIATIVE THERAPY; PARESTHESIA; PERIPHERAL ISCHEMIA; PRESSURE SENSE; REVIEW; SIDE EFFECT; SOMNOLENCE; SYNCOPE; TACHYCARDIA; TREMOR; ACUTE DISEASE; DRUG CONTRAINDICATION;

ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIEMETICS; CLINICAL TRIALS; ERGOT ALKALOIDS; HUMANS; MIGRAINE DISORDERS; SEROTONIN AGONISTS; SUMATRIPTAN;

EID: 16544362952     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-004-0266-8     Document Type: Review

References (11)

1. Maier HW (1926) L'ergotamine inhibitteur du sympathique etudie en clinique, comme moyen d'exploration et comme agent therapeutique. Rev Neurol 33:1104-1108
2. Tfelt-Hansen P, Saxena PR (2000) Ergot alkaloids in the acute treatment of migraine. In: Olesen J, Tfelt-Hansen P, Welch KMA (eds) The headaches, 2nd Edn. Lippincott Williams & Wilkins, Philadelphia, pp 399-409
3. Lipton RB, Bigal ME, Goadsby PJ (2004) Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review. Cephalalgia 24:321-332
4. Markowitz S, Saito K, Moskowitz MA (1988) Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalalgia 8:83-91
5. Tfelt-Hansen P, McEwen J (2000) Nonsteroidal antiinflammatory drugs in the acute treatment of migraine. In: Olesen J, Tfelt-Hansen P, Welch KMA (eds) The headaches, 2nd Edn. Lippincott Williams & Wilkins, Philadelphia, pp 391-397
6. Cashman JN (1996) The mechanisms of action of NSAIDs in analgesia. Drugs 52[Suppl 5]:13-23
7. Saxena PR, Tfelt-Hansen P (2000) Triptans, 5-HT1B/1D receptor agonists in the acute treatment of migraine. In: Olesen J, Tfelt-Hansen P, Welch KMA (eds) The headaches, 2nd Edn. Lippincott Williams & Wilkins, Philadelphia, pp 411-438
8. Ferrari MD, Goadsby PJ, Roon KI, Lipton RB (2002) Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 22:633-658
9. Tfelt-Hansen P (2000) Antiemetic, prokinetic, neuroleptic, and miscellaneous drugs in the acute treatment of migraine. In: Olesen J, Tfelt-Hansen P, Welch KMA (eds) The headaches, 2nd Edn. Lippincott Williams & Wilkins, Philadelphia, pp 445-452
10. Silberstein S, Tepper S, Brandes J, Diamond M, Goldstein J, Winner P, Venkatraman S, Vrijens F, Malbecq W, Lines C, Visser WH, Reines S, Yuen E (2004) Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine. Neurology 62:1552-1557
11. Lipton RB, Stewart WF, Stone AM, Lainez MJ, Sawyer JP (2000) Stratified care is more effective than step care strategies for migraine: results of the disability in strategies of care (DISC) study. JAMA 284:2599-2605